In the last 12 months, insiders at Q32 Bio Inc. ($QTTB) filed 205 transactions with the SEC: 0 open-market purchases totaling $0 and 25 sales totaling $296,787. Net insider sentiment: net selling.
Q32 Bio Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Morrison Jodie Pope (CEO) — 14 transactions totaling $141,445
- Violette Shelia M. (Chief Scientific Officer) — 20 transactions totaling $117,600
- Kalowski Lee (CFO and President) — 10 transactions totaling $57,067
- Alloway Paul (See Remarks) — 19 transactions totaling $30,768
- TZIANABOS ARTHUR (Director) — 5 transactions totaling $14,762
View all SEC Filings for Q32 Bio Inc. (QTTB).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 24, 2026 | Violette Shelia M. | Chief Scientific Officer | A | Common Stock | 37500 | $0.00 | 129,346.0000 | 12,304,352 | 40.83% | 0.30% |
| Feb. 24, 2026 | Kalowski Lee | CFO and President | A | Common Stock | 53250 | $0.00 | 89,193.0000 | 12,304,352 | 148.15% | 0.43% |
| Feb. 24, 2026 | Morrison Jodie Pope | CEO | A | Common Stock | 132000 | $0.00 | 221,104.0000 | 12,304,352 | 148.14% | 1.07% |
| Feb. 25, 2026 | Violette Shelia M. | Chief Scientific Officer | S | Common Stock | 2815 | $4.51 | 91,846.0000 | 12,304,352 | 2.97% | 0.02% |
| Feb. 25, 2026 | Kalowski Lee | CFO and President | S | Common Stock | 3995 | $4.51 | 35,943.0000 | 12,304,352 | 10.00% | 0.03% |
| Feb. 25, 2026 | Morrison Jodie Pope | CEO | S | Common Stock | 9896 | $4.51 | 89,104.0000 | 12,304,352 | 10.00% | 0.08% |
| Jan. 15, 2026 | LAPORTE KATHLEEN | Not found | A | Stock Option (Right to Buy) | 23272 | $2.75 | 23,272.0000 | 12,304,352 | 9999.99% | 0.19% |
| Jan. 15, 2026 | GRAYZEL DAVID S. | Not found | A | Stock Option (Right to Buy) | 16363 | $2.75 | 16,363.0000 | 12,304,352 | 9999.99% | 0.13% |
| Jan. 15, 2026 | Lundberg Sven Ante | Not found | A | Stock Option (Right to Buy) | 20363 | $2.75 | 20,363.0000 | 12,304,352 | 9999.99% | 0.17% |
| Dec. 2, 2025 | Kalowski Lee | CFO and President | S | Common Stock | 9072 | $3.46 | 39,938.0000 | 12,304,352 | 18.51% | 0.07% |
| Dec. 2, 2025 | Morrison Jodie Pope | CEO | S | Common Stock | 22506 | $3.46 | 99,000.0000 | 12,304,352 | 18.52% | 0.18% |
| Oct. 23, 2025 | LAPORTE KATHLEEN | Not found | A | Stock Option (Right to Buy) | 53521 | $0.00 | 53,521.0000 | 12,197,615 | 9999.99% | 0.44% |
| Oct. 23, 2025 | TZIANABOS ARTHUR | Not found | A | Stock Option (Right to Buy) | 53521 | $0.00 | 53,521.0000 | 12,197,615 | 9999.99% | 0.44% |
| Oct. 23, 2025 | GRAYZEL DAVID S. | Not found | A | Stock Option (Right to Buy) | 53521 | $0.00 | 53,521.0000 | 12,197,615 | 9999.99% | 0.44% |
| Oct. 23, 2025 | Thistle Mary | Not found | A | Stock Option (Right to Buy) | 53521 | $0.00 | 53,521.0000 | 12,197,615 | 9999.99% | 0.44% |
| Oct. 23, 2025 | Xu Diyong | Not found | A | Stock Option (Right to Buy) | 53521 | $0.00 | 53,521.0000 | 12,197,615 | 9999.99% | 0.44% |
| Oct. 23, 2025 | Manke Isaac | Not found | A | Stock Option (Right to Buy) | 53521 | $0.00 | 53,521.0000 | 12,197,615 | 9999.99% | 0.44% |
| Oct. 23, 2025 | Iwicki Mark T | Not found | A | Stock Option (Right to Buy) | 53521 | $0.00 | 53,521.0000 | 12,197,615 | 9999.99% | 0.44% |
| Oct. 23, 2025 | Lundberg Sven Ante | Not found | A | Stock Option (Right to Buy) | 53521 | $0.00 | 53,521.0000 | 12,197,615 | 9999.99% | 0.44% |
| Aug. 26, 2025 | Kalowski Lee | CFO and President | S | Common Stock | 4240 | $1.80 | 49,010.0000 | 12,197,615 | 7.96% | 0.03% |
| Aug. 26, 2025 | Violette Shelia M. | Chief Scientific Officer | S | Common Stock | 2990 | $1.80 | 94,661.0000 | 12,197,615 | 3.06% | 0.02% |
| Aug. 26, 2025 | Morrison Jodie Pope | CEO | S | Common Stock | 10494 | $1.80 | 121,506.0000 | 12,197,615 | 7.95% | 0.09% |
| Feb. 24, 2025 | Kalowski Lee | CFO and President | D | Stock Option (Right to Buy) | 16901 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 24, 2025 | TZIANABOS ARTHUR | Not found | D | Stock Option (Right to Buy) | 25674 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 24, 2025 | TZIANABOS ARTHUR | Not found | A | Stock Option (Right to Buy) | 25674 | $0.00 | 25,674.0000 | 0 | 9999.99% | 0.00% |
| Feb. 24, 2025 | TZIANABOS ARTHUR | Not found | D | Stock Option (Right to Buy) | 12767 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 24, 2025 | TZIANABOS ARTHUR | Not found | A | Stock Option (Right to Buy) | 12767 | $0.00 | 12,767.0000 | 0 | 9999.99% | 0.00% |
| Feb. 24, 2025 | Manke Isaac | Not found | A | Stock Option (Right to Buy) | 12767 | $0.00 | 12,767.0000 | 0 | 9999.99% | 0.00% |
| Feb. 24, 2025 | Manke Isaac | Not found | D | Stock Option (Right to Buy) | 2627 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 24, 2025 | Manke Isaac | Not found | A | Stock Option (Right to Buy) | 2627 | $0.00 | 2,627.0000 | 0 | 9999.99% | 0.00% |
| Jan. 15, 2025 | Manke Isaac | Not found | A | Stock Option (Right to Buy) | 19008 | $0.00 | 19,008.0000 | 0 | 9999.99% | 0.00% |
| Feb. 24, 2025 | Manke Isaac | Not found | D | Stock Option (Right to Buy) | 19008 | $0.00 | 0.0000 | 0 | 0.00% | 0.00% |
| Feb. 24, 2025 | Manke Isaac | Not found | A | Stock Option (Right to Buy) | 19008 | $0.00 | 19,008.0000 | 0 | 9999.99% | 0.00% |
| Feb. 24, 2025 | Kalowski Lee | CFO and President | A | Common Stock | 53250 | $0.00 | 53,250.0000 | 0 | 9999.99% | 0.00% |
| Feb. 24, 2025 | Kalowski Lee | CFO and President | A | Stock Option (Right to Buy) | 16901 | $0.00 | 16,901.0000 | 0 | 9999.99% | 0.00% |
| Feb. 24, 2025 | Kalowski Lee | CFO and President | D | Stock Option (Right to Buy) | 161323 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 24, 2025 | Kalowski Lee | CFO and President | A | Stock Option (Right to Buy) | 161323 | $0.00 | 161,323.0000 | 0 | 9999.99% | 0.00% |
| Feb. 24, 2025 | Manke Isaac | Not found | D | Stock Option (Right to Buy) | 12767 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 24, 2025 | LAPORTE KATHLEEN | Not found | D | Stock Option (Right to Buy) | 5431 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 24, 2025 | LAPORTE KATHLEEN | Not found | A | Stock Option (Right to Buy) | 5431 | $0.00 | 5,431.0000 | 0 | 9999.99% | 0.00% |
| Feb. 24, 2025 | LAPORTE KATHLEEN | Not found | D | Stock Option (Right to Buy) | 1947 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 24, 2025 | LAPORTE KATHLEEN | Not found | A | Stock Option (Right to Buy) | 1947 | $0.00 | 1,947.0000 | 0 | 9999.99% | 0.00% |
| Feb. 24, 2025 | LAPORTE KATHLEEN | Not found | D | Stock Option (Right to Buy) | 12767 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 24, 2025 | LAPORTE KATHLEEN | Not found | A | Stock Option (Right to Buy) | 12767 | $0.00 | 12,767.0000 | 0 | 9999.99% | 0.00% |
| Feb. 24, 2025 | Violette Shelia M. | Chief Scientific Officer | D | Stock Option (Right to Buy) | 17506 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 24, 2025 | Campagna Jason | Chief Medical Officer | A | Stock Option (Right to Buy) | 70687 | $0.00 | 70,687.0000 | 0 | 9999.99% | 0.00% |
| Feb. 24, 2025 | GRAYZEL DAVID S. | Not found | D | Stock Option (Right to Buy) | 12767 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 24, 2025 | GRAYZEL DAVID S. | Not found | A | Stock Option (Right to Buy) | 12767 | $0.00 | 12,767.0000 | 0 | 9999.99% | 0.00% |
| Feb. 24, 2025 | GRAYZEL DAVID S. | Not found | D | Stock Option (Right to Buy) | 2569 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 24, 2025 | GRAYZEL DAVID S. | Not found | A | Stock Option (Right to Buy) | 2569 | $0.00 | 2,569.0000 | 0 | 9999.99% | 0.00% |
| Jan. 15, 2025 | GRAYZEL DAVID S. | Not found | A | Stock Option (Right to Buy) | 18595 | $0.00 | 18,595.0000 | 0 | 9999.99% | 0.00% |
| Feb. 24, 2025 | GRAYZEL DAVID S. | Not found | D | Stock Option (Right to Buy) | 18595 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 24, 2025 | GRAYZEL DAVID S. | Not found | A | Stock Option (Right to Buy) | 18595 | $0.00 | 18,595.0000 | 0 | 9999.99% | 0.00% |
| Feb. 24, 2025 | Thistle Mary | Not found | D | Stock Option (Right to Buy) | 12767 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 24, 2025 | Thistle Mary | Not found | A | Stock Option (Right to Buy) | 12767 | $0.00 | 12,767.0000 | 0 | 9999.99% | 0.00% |
| Feb. 24, 2025 | Violette Shelia M. | Chief Scientific Officer | A | Common Stock | 37500 | $0.00 | 97,651.0000 | 0 | 62.34% | 0.00% |
| Feb. 24, 2025 | Violette Shelia M. | Chief Scientific Officer | D | Stock Option (Right to Buy) | 32891 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 24, 2025 | Violette Shelia M. | Chief Scientific Officer | A | Stock Option (Right to Buy) | 32891 | $0.00 | 32,891.0000 | 0 | 9999.99% | 0.00% |
| Feb. 24, 2025 | Violette Shelia M. | Chief Scientific Officer | D | Stock Option (Right to Buy) | 13305 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 24, 2025 | Violette Shelia M. | Chief Scientific Officer | A | Stock Option (Right to Buy) | 13305 | $0.00 | 13,305.0000 | 0 | 9999.99% | 0.00% |
| Feb. 24, 2025 | Campagna Jason | Chief Medical Officer | D | Stock Option (Right to Buy) | 70687 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 24, 2025 | Violette Shelia M. | Chief Scientific Officer | A | Stock Option (Right to Buy) | 17506 | $0.00 | 17,506.0000 | 0 | 9999.99% | 0.00% |
| Feb. 24, 2025 | Violette Shelia M. | Chief Scientific Officer | D | Stock Option (Right to Buy) | 56413 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 24, 2025 | Violette Shelia M. | Chief Scientific Officer | A | Stock Option (Right to Buy) | 56413 | $0.00 | 56,413.0000 | 0 | 9999.99% | 0.00% |
| Feb. 24, 2025 | Lundberg Sven Ante | Not found | D | Stock Option (Right to Buy) | 2013 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 24, 2025 | Lundberg Sven Ante | Not found | A | Stock Option (Right to Buy) | 2013 | $0.00 | 2,013.0000 | 0 | 9999.99% | 0.00% |
| Feb. 24, 2025 | Lundberg Sven Ante | Not found | D | Stock Option (Right to Buy) | 6238 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 24, 2025 | Lundberg Sven Ante | Not found | A | Stock Option (Right to Buy) | 6238 | $0.00 | 6,238.0000 | 0 | 9999.99% | 0.00% |
| Feb. 24, 2025 | Lundberg Sven Ante | Not found | D | Stock Option (Right to Buy) | 2880 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 24, 2025 | Lundberg Sven Ante | Not found | A | Stock Option (Right to Buy) | 2880 | $0.00 | 2,880.0000 | 0 | 9999.99% | 0.00% |
| Feb. 24, 2025 | Lundberg Sven Ante | Not found | D | Stock Option (Right to Buy) | 12767 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 24, 2025 | Lundberg Sven Ante | Not found | A | Stock Option (Right to Buy) | 12767 | $0.00 | 12,767.0000 | 0 | 9999.99% | 0.00% |
| Feb. 24, 2025 | Lundberg Sven Ante | Not found | D | Stock Option (Right to Buy) | 1316 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 15, 2025 | Lundberg Sven Ante | Not found | A | Stock Option (Right to Buy) | 23140 | $0.00 | 23,140.0000 | 0 | 9999.99% | 0.00% |
| Feb. 24, 2025 | Lundberg Sven Ante | Not found | D | Stock Option (Right to Buy) | 23140 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 24, 2025 | Lundberg Sven Ante | Not found | A | Stock Option (Right to Buy) | 23140 | $0.00 | 23,140.0000 | 0 | 9999.99% | 0.00% |
| Feb. 24, 2025 | Morrison Jodie Pope | CEO | D | Stock Option (Right to Buy) | 394445 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 24, 2025 | Morrison Jodie Pope | CEO | A | Stock Option (Right to Buy) | 394445 | $0.00 | 394,445.0000 | 0 | 9999.99% | 0.00% |
| Feb. 24, 2025 | Xu Diyong | Not found | D | Stock Option (Right to Buy) | 12767 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 24, 2025 | Xu Diyong | Not found | A | Stock Option (Right to Buy) | 12767 | $0.00 | 12,767.0000 | 0 | 9999.99% | 0.00% |
| Feb. 24, 2025 | Iwicki Mark T | Not found | D | Stock Option (Right to Buy) | 37222 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 24, 2025 | Iwicki Mark T | Not found | A | Stock Option (Right to Buy) | 37222 | $0.00 | 37,222.0000 | 0 | 9999.99% | 0.00% |
| Feb. 24, 2025 | Iwicki Mark T | Not found | D | Stock Option (Right to Buy) | 7615 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 24, 2025 | Iwicki Mark T | Not found | A | Stock Option (Right to Buy) | 7615 | $0.00 | 7,615.0000 | 0 | 9999.99% | 0.00% |
| Feb. 24, 2025 | Iwicki Mark T | Not found | D | Stock Option (Right to Buy) | 25534 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 24, 2025 | Iwicki Mark T | Not found | A | Stock Option (Right to Buy) | 25534 | $0.00 | 25,534.0000 | 0 | 9999.99% | 0.00% |
| Feb. 24, 2025 | Campagna Jason | Chief Medical Officer | A | Common Stock | 37500 | $0.00 | 37,500.0000 | 0 | 9999.99% | 0.00% |
| Feb. 24, 2025 | Campagna Jason | Chief Medical Officer | D | Stock Option (Right to Buy) | 87738 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 24, 2025 | Campagna Jason | Chief Medical Officer | A | Stock Option (Right to Buy) | 87738 | $0.00 | 87,738.0000 | 0 | 9999.99% | 0.00% |
| Feb. 24, 2025 | Campagna Jason | Chief Medical Officer | D | Stock Option (Right to Buy) | 17951 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 24, 2025 | Campagna Jason | Chief Medical Officer | A | Stock Option (Right to Buy) | 17951 | $0.00 | 17,951.0000 | 0 | 9999.99% | 0.00% |
| Feb. 24, 2025 | Morrison Jodie Pope | CEO | D | Stock Option (Right to Buy) | 152700 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 24, 2025 | Morrison Jodie Pope | CEO | A | Stock Option (Right to Buy) | 152700 | $0.00 | 152,700.0000 | 0 | 9999.99% | 0.00% |
| Feb. 24, 2025 | Morrison Jodie Pope | CEO | A | Stock Option (Right to Buy) | 152700 | $0.00 | 152,700.0000 | 0 | 9999.99% | 0.00% |
| Feb. 24, 2025 | Morrison Jodie Pope | CEO | D | Stock Option (Right to Buy) | 152700 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 24, 2025 | Morrison Jodie Pope | CEO | A | Common Stock | 132000 | $0.00 | 132,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 24, 2025 | Morrison Jodie Pope | CEO | D | Stock Option (Right to Buy) | 16901 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 24, 2025 | Morrison Jodie Pope | CEO | A | Stock Option (Right to Buy) | 16901 | $0.00 | 16,901.0000 | 0 | 9999.99% | 0.00% |
| Oct. 11, 2024 | Violette Shelia M. | Chief Scientific Officer | M | Common Stock | 4574 | $3.12 | 54,151.0000 | 0 | 9.23% | 0.00% |
| Oct. 15, 2024 | Violette Shelia M. | Chief Scientific Officer | M | Common Stock | 6000 | $7.29 | 60,151.0000 | 0 | 11.08% | 0.00% |
| Oct. 11, 2024 | Violette Shelia M. | Chief Scientific Officer | M | Stock Option (Right to Buy) | 213 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 11, 2024 | Violette Shelia M. | Chief Scientific Officer | M | Stock Option (Right to Buy) | 4361 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 15, 2024 | Violette Shelia M. | Chief Scientific Officer | M | Stock Option (Right to Buy) | 6000 | $0.00 | 32,891.0000 | 0 | 15.43% | 0.00% |
| Oct. 8, 2024 | Violette Shelia M. | Chief Scientific Officer | M | Common Stock | 13300 | $3.12 | 49,577.0000 | 0 | 36.66% | 0.00% |
| Oct. 8, 2024 | Violette Shelia M. | Chief Scientific Officer | M | Stock Option (Right to Buy) | 13300 | $0.00 | 213.0000 | 0 | 98.42% | 0.00% |
| April 1, 2024 | Manke Isaac | Not found | A | Stock Option (Right to Buy) | 2627 | $13.42 | 2,627.0000 | 0 | 9999.99% | 0.00% |
| Sept. 25, 2024 | Lundberg Sven Ante | Not found | A | Stock Option (Right to Buy) | 1316 | $0.00 | 1,316.0000 | 0 | 9999.99% | 0.00% |
| April 1, 2024 | GRAYZEL DAVID S. | Not found | A | Stock Option (Right to Buy) | 2569 | $13.42 | 2,569.0000 | 0 | 9999.99% | 0.00% |
| March 25, 2024 | TZIANABOS ARTHUR | Not found | M | Common Stock | 1095 | $0.00 | 8,248.0000 | 0 | 15.31% | 0.00% |
| March 25, 2024 | TZIANABOS ARTHUR | Not found | S | Common Stock | 265 | $24.20 | 7,983.0000 | 0 | 3.21% | 0.00% |
| March 25, 2024 | TZIANABOS ARTHUR | Not found | M | Restricted Stock Units | 1095 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| March 25, 2024 | Alloway Paul | See Remarks | S | Common Stock | 268 | $24.21 | 2,596.0000 | 0 | 9.36% | 0.00% |
| March 25, 2024 | Michaud Charles Jr | See Remarks | S | Common Stock | 75 | $24.20 | 927.0000 | 0 | 7.49% | 0.00% |
| March 25, 2024 | Lundberg Sven Ante | Not found | A | Stock Option (Right to Buy) | 12767 | $0.00 | 12,767.0000 | 0 | 9999.99% | 0.00% |
| March 25, 2024 | TZIANABOS ARTHUR | Not found | A | Stock Option (Right to Buy) | 12767 | $0.00 | 12,767.0000 | 0 | 9999.99% | 0.00% |
| March 25, 2024 | Manke Isaac | Not found | A | Stock Option (Right to Buy) | 12767 | $0.00 | 12,767.0000 | 0 | 9999.99% | 0.00% |
| March 25, 2024 | Iwicki Mark T | Not found | A | Stock Option (Right to Buy) | 25534 | $0.00 | 25,534.0000 | 0 | 9999.99% | 0.00% |
| March 25, 2024 | GRAYZEL DAVID S. | Not found | A | Stock Option (Right to Buy) | 12767 | $0.00 | 12,767.0000 | 0 | 9999.99% | 0.00% |
| March 25, 2024 | Xu Diyong | Not found | A | Stock Option (Right to Buy) | 12767 | $0.00 | 12,767.0000 | 0 | 9999.99% | 0.00% |
| March 25, 2024 | Campagna Jason | Chief Medical Officer | A | Stock Option (Right to Buy) | 70687 | $0.00 | 70,687.0000 | 0 | 9999.99% | 0.00% |
| March 25, 2024 | Morrison Jodie Pope | CEO | A | Stock Option (Right to Buy) | 394445 | $0.00 | 394,445.0000 | 0 | 9999.99% | 0.00% |
| March 25, 2024 | Violette Shelia M. | Chief Scientific Officer | A | Stock Option (Right to Buy) | 56413 | $0.00 | 56,413.0000 | 0 | 9999.99% | 0.00% |
| March 25, 2024 | LAPORTE KATHLEEN | Not found | A | Stock Option (Right to Buy) | 12767 | $0.00 | 12,767.0000 | 0 | 9999.99% | 0.00% |
| March 25, 2024 | Kalowski Lee | CFO and President | A | Stock Option (Right to Buy) | 161323 | $0.00 | 161,323.0000 | 0 | 9999.99% | 0.00% |
| March 25, 2024 | Thistle Mary | Not found | A | Stock Option (Right to Buy) | 12767 | $0.00 | 12,767.0000 | 0 | 9999.99% | 0.00% |
| March 25, 2024 | Alloway Paul | See Remarks | M | Common Stock | 23530 | $0.00 | 51,566.0000 | 0 | 83.93% | 0.00% |
| March 25, 2024 | Alloway Paul | See Remarks | M | Restricted Stock Units | 5440 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| March 25, 2024 | Alloway Paul | See Remarks | M | Restricted Stock Units | 18090 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| March 25, 2024 | Michaud Charles Jr | See Remarks | M | Common Stock | 6448 | $0.00 | 18,046.0000 | 0 | 55.60% | 0.00% |
| March 25, 2024 | Michaud Charles Jr | See Remarks | M | Restricted Stock Units | 1088 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| March 25, 2024 | Michaud Charles Jr | See Remarks | M | Restricted Stock Units | 5360 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 1, 2024 | TZIANABOS ARTHUR | Not found | M | Common Stock | 19140 | $0.00 | 141,815.0000 | 0 | 15.60% | 0.00% |
| Jan. 9, 2024 | TZIANABOS ARTHUR | Not found | S | Common Stock | 13037 | $0.57 | 128,778.0000 | 0 | 9.19% | 0.00% |
| Jan. 1, 2024 | TZIANABOS ARTHUR | Not found | M | Restricted Stock Units | 14280 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 1, 2024 | TZIANABOS ARTHUR | Not found | M | Restricted Stock Units | 19140 | $0.00 | 19,720.0000 | 0 | 49.25% | 0.00% |
| Jan. 1, 2024 | TZIANABOS ARTHUR | Not found | M | Common Stock | 14280 | $0.00 | 122,675.0000 | 0 | 13.17% | 0.00% |
| Jan. 3, 2024 | Alloway Paul | See Remarks | S | Common Stock | 7280 | $0.57 | 28,036.0000 | 0 | 20.61% | 0.00% |
| Jan. 3, 2024 | Michaud Charles Jr | See Remarks | S | Common Stock | 1708 | $0.57 | 11,598.0000 | 0 | 12.84% | 0.00% |
| Jan. 1, 2024 | Alloway Paul | See Remarks | M | Restricted Stock Units | 5280 | $0.00 | 5,440.0000 | 0 | 49.25% | 0.00% |
| Jan. 1, 2024 | Alloway Paul | See Remarks | M | Common Stock | 4420 | $0.00 | 21,126.0000 | 0 | 26.46% | 0.00% |
| Jan. 1, 2024 | Alloway Paul | See Remarks | M | Restricted Stock Units | 4420 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 1, 2024 | Alloway Paul | See Remarks | M | Common Stock | 8910 | $0.00 | 35,316.0000 | 0 | 33.74% | 0.00% |
| Jan. 1, 2024 | Alloway Paul | See Remarks | M | Common Stock | 5280 | $0.00 | 26,406.0000 | 0 | 24.99% | 0.00% |
| Jan. 1, 2024 | Michaud Charles Jr | See Remarks | M | Restricted Stock Units | 1056 | $0.00 | 1,088.0000 | 0 | 49.25% | 0.00% |
| Jan. 1, 2024 | Michaud Charles Jr | See Remarks | M | Restricted Stock Units | 544 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 1, 2024 | Michaud Charles Jr | See Remarks | M | Common Stock | 2640 | $0.00 | 13,306.0000 | 0 | 24.75% | 0.00% |
| Jan. 1, 2024 | Michaud Charles Jr | See Remarks | M | Common Stock | 1056 | $0.00 | 10,666.0000 | 0 | 10.99% | 0.00% |
| Jan. 1, 2024 | Michaud Charles Jr | See Remarks | M | Restricted Stock Units | 2640 | $0.00 | 5,360.0000 | 0 | 33.00% | 0.00% |
| Jan. 1, 2024 | Michaud Charles Jr | See Remarks | M | Common Stock | 544 | $0.00 | 9,610.0000 | 0 | 6.00% | 0.00% |
| Jan. 1, 2024 | Alloway Paul | See Remarks | M | Restricted Stock Units | 8910 | $0.00 | 18,090.0000 | 0 | 33.00% | 0.00% |
| Sept. 6, 2023 | Seymour Albert | See Remarks | M | Restricted Stock Units | 4620 | $0.00 | 9,380.0000 | 0 | 33.00% | 0.00% |
| Sept. 6, 2023 | Seymour Albert | See Remarks | S | Common Stock | 1448 | $1.15 | 150,874.0000 | 0 | 0.95% | 0.00% |
| Sept. 6, 2023 | Seymour Albert | See Remarks | M | Common Stock | 4620 | $0.00 | 152,322.0000 | 0 | 3.13% | 0.00% |
| Aug. 3, 2023 | Jordan Julie | Chief Medical Officer | M | Restricted Stock Units | 4644 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Aug. 3, 2023 | Jordan Julie | Chief Medical Officer | S | Common Stock | 1308 | $1.39 | 7,496.0000 | 0 | 14.86% | 0.00% |
| Aug. 3, 2023 | Jordan Julie | Chief Medical Officer | M | Restricted Stock Units | 1548 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Aug. 3, 2023 | Jordan Julie | Chief Medical Officer | M | Restricted Stock Units | 387 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Aug. 3, 2023 | Jordan Julie | Chief Medical Officer | M | Common Stock | 387 | $0.00 | 4,269.0000 | 0 | 9.97% | 0.00% |
| Aug. 3, 2023 | Jordan Julie | Chief Medical Officer | M | Common Stock | 1548 | $0.00 | 4,318.0000 | 0 | 55.88% | 0.00% |
| Aug. 3, 2023 | Jordan Julie | Chief Medical Officer | S | Common Stock | 436 | $1.39 | 3,882.0000 | 0 | 10.10% | 0.00% |
| Aug. 3, 2023 | Jordan Julie | Chief Medical Officer | S | Common Stock | 109 | $1.39 | 4,160.0000 | 0 | 2.55% | 0.00% |
| Aug. 3, 2023 | Jordan Julie | Chief Medical Officer | M | Common Stock | 4644 | $0.00 | 8,804.0000 | 0 | 111.63% | 0.00% |
| Aug. 2, 2023 | Jordan Julie | Chief Medical Officer | M | Restricted Stock Units | 350 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Aug. 2, 2023 | Jordan Julie | Chief Medical Officer | S | Common Stock | 99 | $1.31 | 2,770.0000 | 0 | 3.45% | 0.00% |
| Aug. 2, 2023 | Jordan Julie | Chief Medical Officer | M | Common Stock | 350 | $0.00 | 2,869.0000 | 0 | 13.89% | 0.00% |
| June 14, 2023 | Poulton Jeffrey V. | Not found | A | Option (Right to Buy) | 23000 | $0.00 | 23,000.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2023 | REICIN ALISE | Not found | A | Option (Right to Buy) | 23000 | $0.00 | 23,000.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2023 | GILLIS STEVEN | Not found | A | Option (Right to Buy) | 23000 | $0.00 | 23,000.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2023 | Patterson Matthew R | Not found | A | Option (Right to Buy) | 23000 | $0.00 | 23,000.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2023 | Thistle Mary | Not found | A | Option (Right to Buy) | 23000 | $0.00 | 23,000.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2023 | TZIANABOS ARTHUR | Not found | A | Option (Right to Buy) | 23000 | $0.00 | 23,000.0000 | 0 | 9999.99% | 0.00% |
| March 2, 2023 | Alloway Paul | See Remarks | S | Common Stock | 10965 | $1.45 | 16,706.0000 | 0 | 39.63% | 0.00% |
| Feb. 23, 2023 | Smith W Bradford | See remarks | A | Employee Stock Option (Right to Buy) | 213000 | $0.00 | 213,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 23, 2023 | Alloway Paul | See Remarks | A | Employee Stock Option (Right to Buy) | 164000 | $0.00 | 164,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 23, 2023 | Alloway Paul | See Remarks | A | Restricted Stock Units | 27000 | $0.00 | 27,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 23, 2023 | Blum Michael Lee | Chief Commercial Officer | A | Employee Stock Option (Right to Buy) | 104000 | $0.00 | 104,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 23, 2023 | Blum Michael Lee | Chief Commercial Officer | A | Restricted Stock Units | 17000 | $0.00 | 17,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 23, 2023 | Smith W Bradford | See remarks | A | Restricted Stock Units | 36000 | $0.00 | 36,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 23, 2023 | Seymour Albert | See Remarks | A | Employee Stock Option (Right to Buy) | 632000 | $0.00 | 632,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 23, 2023 | Seymour Albert | See Remarks | A | Restricted Stock Units | 105000 | $0.00 | 105,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 9, 2023 | TZIANABOS ARTHUR | Director | S | Common Stock | 10616 | $1.39 | 108,395.0000 | 0 | 8.92% | 0.00% |
| Jan. 9, 2023 | Seymour Albert | See Remarks | S | Common Stock | 3620 | $1.39 | 143,166.0000 | 0 | 2.47% | 0.00% |
| Jan. 9, 2023 | Smith W Bradford | See Remarks | S | Common Stock | 3729 | $1.39 | 14,219.0000 | 0 | 20.78% | 0.00% |
| Jan. 9, 2023 | Alloway Paul | See Remarks | S | Common Stock | 3090 | $1.39 | 20,103.0000 | 0 | 13.32% | 0.00% |
| Jan. 9, 2023 | Blum Michael Lee | Chief Commercial Officer | S | Common Stock | 2454 | $1.39 | 13,538.0000 | 0 | 15.35% | 0.00% |
| Jan. 1, 2023 | Seymour Albert | See Remarks | M | Common Stock | 4290 | $0.00 | 139,856.0000 | 0 | 3.16% | 0.00% |
| Jan. 1, 2023 | Seymour Albert | See Remarks | M | Common Stock | 6930 | $0.00 | 146,786.0000 | 0 | 4.96% | 0.00% |
| Jan. 1, 2023 | Seymour Albert | See Remarks | M | Restricted Stock Units | 4290 | $0.00 | 4,420.0000 | 0 | 49.25% | 0.00% |
| Jan. 1, 2023 | Seymour Albert | See Remarks | M | Restricted Stock Units | 6930 | $0.00 | 14,070.0000 | 0 | 33.00% | 0.00% |
| Jan. 1, 2023 | Smith W Bradford | See Remarks | M | Common Stock | 6600 | $0.00 | 11,018.0000 | 0 | 149.39% | 0.00% |
| Jan. 1, 2023 | Smith W Bradford | See Remarks | M | Common Stock | 6930 | $0.00 | 17,948.0000 | 0 | 62.90% | 0.00% |
| Jan. 1, 2023 | Smith W Bradford | See Remarks | M | Restricted Stock Units | 6600 | $0.00 | 6,800.0000 | 0 | 49.25% | 0.00% |
| Jan. 1, 2023 | Blum Michael Lee | Chief Commercial Officer | M | Restricted Stock Units | 4950 | $0.00 | 10,050.0000 | 0 | 33.00% | 0.00% |
| Jan. 1, 2023 | Alloway Paul | See Remarks | M | Common Stock | 4290 | $0.00 | 17,913.0000 | 0 | 31.49% | 0.00% |
| Jan. 1, 2023 | Alloway Paul | See Remarks | M | Common Stock | 5280 | $0.00 | 23,193.0000 | 0 | 29.48% | 0.00% |
| Jan. 1, 2023 | Alloway Paul | See Remarks | M | Restricted Stock Units | 4290 | $0.00 | 4,420.0000 | 0 | 49.25% | 0.00% |
| Jan. 1, 2023 | Alloway Paul | See Remarks | M | Restricted Stock Units | 5280 | $0.00 | 10,720.0000 | 0 | 33.00% | 0.00% |
| Jan. 1, 2023 | Blum Michael Lee | Chief Commercial Officer | M | Restricted Stock Units | 2640 | $0.00 | 2,720.0000 | 0 | 49.25% | 0.00% |
| Jan. 1, 2023 | Blum Michael Lee | Chief Commercial Officer | M | Common Stock | 4950 | $0.00 | 15,992.0000 | 0 | 44.83% | 0.00% |
| Jan. 1, 2023 | Blum Michael Lee | Chief Commercial Officer | M | Common Stock | 2640 | $0.00 | 11,042.0000 | 0 | 31.42% | 0.00% |
| Jan. 1, 2023 | Smith W Bradford | See Remarks | M | Restricted Stock Units | 6930 | $0.00 | 14,070.0000 | 0 | 33.00% | 0.00% |
| Jan. 1, 2023 | TZIANABOS ARTHUR | Director | M | Common Stock | 13860 | $0.00 | 99,871.0000 | 0 | 16.11% | 0.00% |
| Jan. 1, 2023 | TZIANABOS ARTHUR | Director | M | Common Stock | 19140 | $0.00 | 119,011.0000 | 0 | 19.16% | 0.00% |
| Jan. 1, 2023 | TZIANABOS ARTHUR | Director | M | Restricted Stock Units | 13860 | $0.00 | 14,280.0000 | 0 | 49.25% | 0.00% |
| Jan. 1, 2023 | TZIANABOS ARTHUR | Director | M | Restricted Stock Units | 19140 | $0.00 | 38,860.0000 | 0 | 33.00% | 0.00% |